Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Zolpidem Tartrate Extended-Release vs. Placebo in Treatment of Insomnia Associated With Newly Diagnosed Major Depressive Disorder(MDD) or Untreated MDD Relapse, When Used Concomitantly With Escitalopram

NCT00296179 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00296179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00296179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Zolpidem Tartrate Extended-Release vs. Placebo in Treatment of Insomnia Associated With Newly Diagnosed Major Depressive Disorder(MDD) or Untreated MDD Relapse, When Used Concomitantly With Escitalopram
Lead sponsor
Sanofi
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2006
Completion date
Not reported
Enrollment
372
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia